News Shire’s new chairman will be second only woman to lead a FTSE 100 Catherine 0 Comment Susan Kilsby, who has been on the board at Shire since leaving a career in investment banking in Share X Shire’s new chairman will be second only woman to lead a FTSE 100 https://pharmaphorum.com/news/shire-s-new-chairman-will-be-second-only-woman-to-lead-a-ftse-100/
Articles/ Views and analysis Diabetes: Tackling a growing global challenge Catherine 0 Comment Enrique Conterno of Eli Lilly and Company addresses the growing challenge of diabetes and discusses how pooling our Share X Diabetes: Tackling a growing global challenge https://pharmaphorum.com/views-and-analysis/diabetes-tackling-a-growing-global-challenge/
Articles/ Views and analysis Commercialisation of biotech assets – learning from the pioneers: part one Catherine 0 Comment Dan Heapy brings strategic marketing expertise to critically assess the approaches taken by the biotech companies – and Share X Commercialisation of biotech assets – learning from the pioneers: part one https://pharmaphorum.com/views-and-analysis/commercialisation-of-biotech-assets-learning-from-the-pioneers-part-one/
Articles/ Views and analysis How to deliver an effective global strategic brand plan Catherine 0 Comment In our ‘Marketing Excellence’ themed month Sunil Ramkali discusses how to deliver an effective pharmaceutical global strategic brand Share X How to deliver an effective global strategic brand plan https://pharmaphorum.com/views-and-analysis/how-to-deliver-an-effective-global-strategic-brand-plan/
Articles/ Views and analysis Communicating diabetes to the online masses – how can pharma take advantage? Catherine 0 Comment Kirsty Pegram explores the opportunity presented to pharma by the global explosion of online diabetes communication. Diabetes has Share X Communicating diabetes to the online masses – how can pharma take advantage? https://pharmaphorum.com/views-and-analysis/communicating-diabetes-to-the-online-masses-how-can-pharma-take-advantage/
Articles/ Views and analysis Personalised medicines: challenges and opportunities Catherine 0 Comment In our personalised medicine themed month, Duncan McHale discusses the barriers to adoption and the benefits of personalised Share X Personalised medicines: challenges and opportunities https://pharmaphorum.com/views-and-analysis/personalised-medicines-challenges-and-opportunities/
Articles/ Views and analysis Using the human genome to guide healthcare decisions Catherine 0 Comment As our personalized medicine month continues, pharmaphorum’s Hannah Blake catches up with Michael Christman, President and CEO of Share X Using the human genome to guide healthcare decisions https://pharmaphorum.com/views-and-analysis/using-the-human-genome-to-guide-healthcare-decisions/
Articles/ Views and analysis A new regulation that we should be pleased with! Catherine 0 Comment Paul Gershlick explores the Falsified Medicines Directive. As a lawyer, I often plead with people: “Don’t shoot the Share X A new regulation that we should be pleased with! https://pharmaphorum.com/views-and-analysis/a-new-regulation-that-we-should-be-pleased-with/
Articles/ Views and analysis Conducting impactful workshops Catherine 0 Comment Kelly Price shares her top tips on how to establish and conduct an impactful workshop. In this digital Share X Conducting impactful workshops https://pharmaphorum.com/views-and-analysis/conducting-impactful-workshops/
